DIABETES EDUCATION CONTROL AND OLDER AFICAN-AMERICANS

糖尿病教育控制和老年非裔美国人

• 批准号: 2258290
• 负责人: Margaret Ingrid Wallhagen
• 金额: $ 11.03万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 1996
• 资助国家: 美国
• 起止时间: 1996-07-01 至 1999-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2258290
• 关键词: African American; caregivers; clinical research; diabetes education; diabetes mellitus therapy; health behavior; human old age (65+); human subject; human therapy evaluation; interview; noninsulin dependent diabetes mellitus; nursing intervention; self care; therapy compliance

DESCRIPTION: (Adapted from investigator's abstract) This randomized, controlled trial pilot study uses triangulation of methods and a person-environment interaction perspective to explore an intervention (IV) in concert with intensive interviews in a sample of older African-Americans (>65) with non-insulin-dependent diabetes mellitus (NIDDM) and their caregivers/diabetes helpers (CGs). The goal is to refine the IV based on a better understanding of the relationship between the impact of the IV and perceived control (PC) of each partner in the dyad. PC is viewed as pivotal to the management of often uncontrollable illnesses such as NIDDM; yet how PC is influenced by the interactions occurring between individuals within a cultural context, how it influences the response of individuals and families to interventions, and how PC is in turn influenced by these interventions remains poorly understood. Understanding these relationships may be crucial if efforts to promote client control of treatment regimens are to be successful. Further, little is known about African-Americans in relation to diabetes management in the family and issues of control. The specific aims are to answer the questions: 1) What is the difference between an experimental group (E) receiving a comprehensive diabetes education IV and a control group (C) not receiving the IV over time in diabetes management and the well-being of both dyadic partners?; 2) What is the relationship of PC between the persons with NIDDM and their CGs? Does this relationship depend on group (E vs C) and/or on time?; 3) Does the PC of each dyadic partner mediate the relationship between the IV and the outcomes of well-being and diabetic management?; and, 4) What sociocultural, personal, and interpersonal factors are identified be each dyadic partner during intensive interviews as influencing PC, the management of diabetes, and the impact of the IV? Thirty African-Americans with NIDDM and their designated CGs will be recruited and randomly assigned to either the experimental (E) or control (C) group. E dyads receive the IV, a 3 day education program and 1 day follow-up at 3 months, that emphasizes the relationship between diet and blood glucose, and provides practice in making food choices among preferred, culturally acceptable foods. Both E and C dyads will be interviewed 3 times across 6 months to answer aim 4. Standard analytic techniques specific for each aim will be used, such as repeated measures ANOVA, regression, and qualitative methods. The refined intervention will be tested in a larger sample with the goal to minimize the multiple personal, social, and health costs of this chronic disease that is often managed by advanced practice nurses.

描述：（根据研究者的摘要进行了改编） 对照试验试验研究使用方法和A 探索干预措施（IV）的人与环境互动的观点 在非裔美国人的样本中与密集的采访一起 （> 65）与非胰岛素依赖性糖尿病（NIDDM）及其 护理人员/糖尿病助手（CGS）。 目的是根据 更好地了解IV和IV的影响之间的关系 二元组中每个伴侣的感知控制（PC）。 PC被视为关键 管理经常无法控制的疾病，例如NIDDM；但是怎么样 PC受到个人之间发生的相互作用的影响 文化背景，如何影响个人和家庭的反应 干预措施，以及PC如何受这些干预措施的影响 仍然很了解。 了解这些关系可能至关重要 如果要促进客户控制治疗方案的努力是 成功的。 此外，关于非裔美国人关于 家庭中的糖尿病管理和控制问题。 具体目标 要回答问题：1） 实验组（E）接受全面的糖尿病教育IV和A 对照组（c）在糖尿病管理中未接受静脉注射，并且 两个二元伙伴的福祉？ 2）PC的关系是什么 在NIDDM及其CGS的人之间？ 这种关系取决于 在组（E vs c）和/或准时？ 3）每个二元合作伙伴的PC 调解IV与幸福感之间的关系 糖尿病管理？ 4）什么社会文化，个人和 在密集型期间，确定每个二元伴侣的人际因素 访谈是影响PC的访谈，糖尿病的管理以及 IV？ NIDDM及其指定的CGS的30名非裔美国人将 被招募并随机分配给实验（E）或对照 （c）组。 E Dyads接受IV，为期3天的教育计划和1天 在3个月的后续行动，这强调了饮食与 血糖，并提供在首选中做出食物选择的练习， 文化上可接受的食物。 E和C DYAD将接受3次采访 在6个月的回答目标4中。 将使用每个目标，例如重复测量方差分析，回归和 定性方法。 精制干预将在较大的 采样的目标是最大程度地减少多个个人，社会和健康 这种慢性疾病的成本通常是由高级实践控制的 护士。